Pulmicort CFC-free range

In line with the global phase-out of chlorofluorocarbon (CFC)-containing inhalers in favour of inhalers that use more environmentally friendly CFC-free propellants, AstraZeneca has launched Pulmicort (budesonide) 200 microgram CFC-free metered dose inhaler (MDI).

This is the latest addition to the company's range of CFC-free MDIs, which includes the Pulmicort 100 microgram CFC-free MDI.

View Pulmicort CFC-free drug record

Further information: AstraZeneca

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Researchers query safety of delaying antibiotics for UTI in elderly

Researchers query safety of delaying antibiotics for UTI in elderly

Delaying or withholding antibiotics for symptoms of...

Ophthalmic Preparations, Preservatives and Potential Sensitisers as Ingredients

Ophthalmic Preparations, Preservatives and Potential Sensitisers as Ingredients

Potential sensitising agents in eye drops and ointments.

Blood Glucose Testing Strips and Meters

Blood Glucose Testing Strips and Meters

Compatible test strips for blood glucose meters.

Asthma and COPD Preparations and Compatible Devices

Asthma and COPD Preparations and Compatible Devices

Available presentations of bronchodilators and anti-inflammatories.